However, as cancer advances, cells become resistant to these effects, and TGF-β switches to a tumor-promoting role, enhancing EMT, invasiveness, metastatic potential, and resistance to therapy [69,70,71,72,73,74]. Here, TGFB1 is linked to neoplasm.